Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor.
Skwarska A, Calder EDD, Sneddon D, Bolland H, Odyniec ML, Mistry IN, Martin J, Folkes LK, Conway SJ, Hammond EM.
Skwarska A, et al. Among authors: calder edd.
Cell Chem Biol. 2021 Sep 16;28(9):1258-1270.e13. doi: 10.1016/j.chembiol.2021.04.004. Epub 2021 Apr 27.
Cell Chem Biol. 2021.
PMID: 33910023
Free PMC article.